eyeforpharma is currently preparing the next conference for October 2013. If you are interested in getting involved, please contact me directly. (Note that the other information on this website refers to the old conference and will be updated shortly.)

Kind regards
Paul Simms, eyeforpharma
psimms@eyeforpharma.com


New Turkey, New Pharma: A fresh mindset to win with all stakeholders. Innovative business models for overcoming price-discounts.

Pharma has evolved and Turkey needs to adapt to its new needs.

Turkey's healthcare landscape has evolved hugely now, on the brink of accession to the EU, there is now big opportunity for pharma to flourish.

Confirmed members of the panel discussion: 'Association's view of the evolution of Turkish Pharma Industry'

Speakers in the panel:

  • Turgut Tokgöz - Secretary General of IEIS
  • Alp Sevindik - Secretary General of AIFD
  • Kemalettin Akalın - Secretary General of TISD

Moderator:

  • Nuri M. Colakoglu - President, Dogan Media International
See the full program

There has never been a better time to adjust local strategy to fit global aims; we have sought out companies who have done so successfully. Moreover, potential for multinational investment in Turkey is well positioned for cheaper R&D, sourcing and home to a highly qualified scientific community. Ensure you are ready to be part of the boom.

Have we got your attention? Great... now read about the agenda in a bit more detail!

Over two days we will map out how to create the ultimate in sales and marketing techniques for you to expand and increase profits for the future, including;

  • Sales Excellence: Understand new demographics to meet their needs whilst creating long term, mutually beneficial relationships through KAM. Learn how and what technology to invest in for maximum ROI.
  • Market Access: Improve time scales for approval and reimbursement as well as how to improve communication flows with stakeholders to ensure your approach is compliant and valuable.
  • Engagement: learn from pilots of new marketing initiatives that have proved successful within Turkey's marketplace and the key steps you need when considering partnering.
  • Generics: How to build a brand that will survive generic competition; case studies from Nezvat and other leading pharma. Prepare for European conglomerate investment through building strong relationships with government.
  • Change Management: Understand changing regulations and adopt new selling techniques through reorganisation of training and recruitment.
Get the complete agenda & speaker lineup instantly via email
Download Now

Speakers include:

Speaker

Güldem Berkman
Country President
Novartis

Speaker

Ayse Uysal
General Manager
Allergan

Speaker

Altan Görseval
Sales & Marketing Director
Lundbeck

Speaker

Levent Selamoğlu
General Manager
Mustafa Nevzat


Speaker

Pelin Eriştiren İncesu
Market Access Director
AstraZeneca

Speaker

Uğur Özkutlu
Market Access Director
Novartis

Speaker

Hulya Yalin
Business Unit Director
Abdi Ibrahim

Speaker

Haluk Karabatak
Head of CauCar (Caucasus & Central Asia) Regional Sales and Marketing
Pfizer


Speaker

Renan Özyerli
Business Unit manager, Inflammation
Pfizer

Speaker

Levent Arslan
Sales Director
J&J

Speaker

Ufuk Apaydin, MBA
Strategic Planning & Business Development Director
Roche

Speaker

Murat Yesildere
General Manager
Egon Zehnder


Speaker

Deniz Durmaz
Business Unit Director
Allergan

Speaker

Leandro Herrero
CEO
The Chalfont Project

Speaker

John Pugh
Director Corporate, Communications
Boehringer Ingelheim

Speaker

Andreas Claus Kistner
Global Head of Commercial, Solution Architecture
Roche


Speaker

Karim Smaira
Former Vice President
Merck Serono

Speaker

Vigo Birch
Vice President Europe
Novo Nordisk

Speaker

Müjgan Ateş
Medical & Regulatory Director
AstraZeneca Turkey

Speaker

Serkan Erkovan
Lead IS
Boehringer Ingelheim


Speaker

Tanyer Sönmezer
General Manager
MCT

Speaker

Kaner Eyuboglu
Medical Relations Manager
L'oréal


What you can expect...

We have sourced the best pharma speakers with experience from inside Turkey's market and Western Europe, providing you with grounded expert knowledge. This event is imperative knowing how leading pharma companies are driving innovation - see all speakers & their presentations here.

In order to stay ahead and make the most of Turkey's opportunities you need to know exactly where pharma is at present and where it is headed; both locally and at large. A panel session of industry experts will talk about working for future change to build a global strategy - see a breakdown of all sessions on this here.

Knowing who and how to interact with is key engagement. This can only be done through water tight marketing. Hear case studies from the likes of Pfizer, J&J and Astra Zeneca on how to breathe life into traditional selling methods with the right technology and sales force models - see which companies with be sharing their insights here.

Get the complete agenda & speaker lineup instantly via email
Download Now

"As MN we are exporting products to about 28 countries. We were the first Turkish company to get FDA approval for our products in the US market and is still the only one. Apart from exporting products we are currently building up a manufacturing plant in China to serve global market, at the same time we are negotiating contracts for joint manufacturing operations in Iraq, Bosnia and Russia. Furthermore, we have several co-developments which are on-going at the moment. The governments are in need of lowering their healthcare burden and quality generic products are one of the most powerful tools they can use without endangering the lives of people."

Levent Selamoglu, General Manager, Mustafa Nevzat's

Sponsors